CME [CME] vs S&P Global [SPGI] Detailed Stock Comparison
CME
NASDAQ
Loading...
S&P Global
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CME wins in 13 metrics, S&P Global wins in 7 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CME | S&P Global | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.52 | 42.37 | CME |
| Price-to-Book Ratio | 3.55 | 5.04 | CME |
| Debt-to-Equity Ratio | 13.60 | 31.65 | CME |
| PEG Ratio | 1.70 | 5.07 | CME |
| EV/EBITDA | 22.08 | 25.21 | CME |
| Profit Margin (TTM) | 58.59% | 27.29% | CME |
| Operating Margin (TTM) | 66.87% | 42.69% | CME |
| EBITDA Margin (TTM) | 66.87% | 42.69% | CME |
| Return on Equity | 13.61% | 11.29% | CME |
| Return on Assets (TTM) | 1.74% | 6.26% | S&P Global |
| Free Cash Flow (TTM) | $3.60B | $5.57B | S&P Global |
| Dividend Yield | 4.30% | 0.55% | CME |
| 1-Year Return | 31.12% | 10.76% | CME |
| Price-to-Sales Ratio (TTM) | 15.35 | 11.45 | S&P Global |
| Enterprise Value | $100.39B | $183.02B | S&P Global |
| EV/Revenue Ratio | 15.61 | 12.45 | S&P Global |
| Gross Profit Margin (TTM) | 86.90% | 70.20% | CME |
| Revenue per Share (TTM) | $18 | $48 | S&P Global |
| Earnings per Share (Diluted) | $10.33 | $13.01 | S&P Global |
| Beta (Stock Volatility) | 0.46 | 1.19 | CME |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CME vs S&P Global Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CME | 1.10% | -1.59% | -1.28% | -2.32% | 8.27% | 16.66% |
| S&P Global | 0.58% | -0.83% | 6.19% | 5.75% | 2.16% | 11.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CME | 31.12% | 38.27% | 53.36% | 186.93% | 428.70% | 404.63% |
| S&P Global | 10.76% | 52.29% | 51.14% | 457.50% | 1,855.66% | 1,058.44% |
Performance & Financial Health Analysis: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Market Information | ||
| Market Cap | $98.72B | $168.28B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,887,200 | 1,049,030 |
| 90 Day Avg. Volume | 2,111,473 | 1,085,040 |
| Last Close | $274.47 | $554.43 |
| 52 Week Range | $206.44 - $290.79 | $427.14 - $579.05 |
| % from 52W High | -5.61% | -4.25% |
| All-Time High | $290.79 (Jun 02, 2025) | $579.05 (Aug 14, 2025) |
| % from All-Time High | -5.61% | -4.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.06% |
| Quarterly Earnings Growth | 0.16% | 0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.59% | 0.27% |
| Operating Margin (TTM) | 0.67% | 0.43% |
| Return on Equity (TTM) | 0.14% | 0.11% |
| Debt to Equity (MRQ) | 13.60 | 31.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $77.13 | $109.37 |
| Cash per Share (MRQ) | $5.82 | $6.05 |
| Operating Cash Flow (TTM) | $4.20B | $5.58B |
| Levered Free Cash Flow (TTM) | $2.92B | $4.93B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.30% | 0.55% |
| Last 12-Month Dividend | $11.85 | $2.78 |
Valuation & Enterprise Metrics Analysis: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.52 | 42.37 |
| Forward P/E | 26.41 | 32.79 |
| PEG Ratio | 1.70 | 5.07 |
| Price to Sales (TTM) | 15.35 | 11.45 |
| Price to Book (MRQ) | 3.55 | 5.04 |
| Market Capitalization | ||
| Market Capitalization | $98.72B | $168.28B |
| Enterprise Value | $100.39B | $183.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 15.61 | 12.45 |
| Enterprise to EBITDA | 22.08 | 25.21 |
| Risk & Other Metrics | ||
| Beta | 0.46 | 1.19 |
| Book Value per Share (MRQ) | $77.13 | $109.37 |
Financial Statements Comparison: CME vs S&P Global
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Revenue/Sales | $1.64B | $3.78B |
| Cost of Goods Sold | $206.70M | $1.15B |
| Gross Profit | $1.44B | $2.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.11B | $1.57B |
| EBITDA | $476.30M | $1.88B |
| Pre-Tax Income | $1.24B | $1.50B |
| Income Tax | $288.60M | $325.00M |
| Net Income (Profit) | $956.20M | $1.17B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Cash & Equivalents | $1.41B | $1.47B |
| Total Current Assets | $123.45B | $5.34B |
| Total Current Liabilities | $121.42B | $5.92B |
| Long-Term Debt | $3.42B | $11.91B |
| Total Shareholders Equity | $27.03B | $37.73B |
| Retained Earnings | $4.69B | $21.80B |
| Property, Plant & Equipment | $371.20M | $1.50B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CME | SPGI |
|---|---|---|
| Operating Cash Flow | $838.30M | $708.00M |
| Capital Expenditures | $-14.20M | N/A |
| Free Cash Flow | $1.10B | $910.00M |
| Debt Repayment | $-750.00M | $-4.00M |
| Common Stock Repurchase | N/A | $-650.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CME | SPGI |
|---|---|---|
| Shares Short | 5.42M | 2.97M |
| Short Ratio | 2.53 | 2.91 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 1,887,200 | 1,049,030 |
| Average Daily Volume (90 Day) | 2,111,473 | 1,085,040 |
| Shares Outstanding | 359.61M | 307.80M |
| Float Shares | 358.78M | 304.63M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.92% | 0.90% |
Dividend Analysis & Yield Comparison: CME vs S&P Global
| Metric | CME | SPGI |
|---|---|---|
| Last 12-Month Dividend | $11.85 | $2.78 |
| Last 12-Month Dividend Yield | 4.30% | 0.55% |
| 3-Year Avg Annual Dividend | $10.10 | $3.00 |
| 3-Year Avg Dividend Yield | 0.91% | 0.21% |
| 3-Year Total Dividends | $30.30 | $9.00 |
| Ex-Dividend Date | Sep 09, 2025 | Feb 26, 2025 |